PBMC from HIV+ individuals were labeled with CFSE and stimulated with HIV peptide (HLA-B57 restricted), KAFSPEVIPMF (KF11) in the presence or absence of Tregs or CD4+ T cell subsets from an HIV negative subject.
More recent world-wide migrations were also considered (e.g. association studies on African American individuals were labeled as African).
To determine the phenotype of cells that were bound by PDL241, 2 × 10 PBMC collected from healthy individuals were labeled for analysis of lymphocytes, while 1 × 10 PBMC were used for analysis of plasma cells and dendritic cells.
Individuals were labelled with consecutive numbers for identification in the data analyses.
Once DCA had been used to produce a two-dimensional plot of the major variation in the dataset, individuals were labelled with their infection status (Fig. 1).
To be included in the study population, individuals were labelled as possible SLE cases based on the diagnosis of a single inpatient or outpatient visit, with the understanding that to reduce misclassification, validated algorithms will be used to define SLE cases in future research.
They are frequently divided in two or three seriousness levels, such as minor and serious offenses, or minor, moderate and serious offenses, or even high and low prevalent offenses, and individuals are labeled according to the level of the most serious offense committed.
Once individuals have been labelled with hypertension, the increase in their absenteeism from work increases by 80% as a direct consequence of the individuals being labelled as 'diseased' [ 3].
Individuals are labelled on the plot as to their infection category: those with syphilis alone (n = 16), those with syphilis and HIV (n = 7), HIV alone (n = 13) and those with neither infection (n = 49).
Corresponding questionnaire, consent form, sputum sample and oral swab for each individual were labelled and anonymously linked using the bar-coded study number.
In brief, 1 × 10 T cells from each individual were labelled with 5 μ M CFSE using CellTrace CFSE Cell Proliferation Kit Life Sciencess, Carlsbad, CA, USA), cultured in RPMI 10 and stimulated with anti-CD3 and anti-CD28 beads (Miltenyi Biotech, Bergisch Gladbach, Germany) at a ratio of 1 1 for 4 days.
